Literature DB >> 25113950

Heart rate control with single administration of a long-acting β-blocker at bedtime before coronary computed tomography angiography.

Kenji Sadamatsu1, Sachiko Koide2, Kayoko Nakano2, Keiki Yoshida3.   

Abstract

BACKGROUND: Beta-blockers are used to control the heart rate prior to coronary computed tomography (CT) angiography. However, in-hospital administration is time-consuming, and it is hard to decrease the heart rate to <60 beats per minute (bpm) when the initial heart rate is increased. In this study, we examined whether the single administration of long-acting β-blocker at bedtime before angiography is effective for achieving the target heart rate. METHODS AND
RESULTS: A total of 314 consecutive patients with a resting heart rate >60bpm who underwent coronary CT angiography were retrospectively collected. Either bisoprolol or atenolol was orally administered the night before to 166 patients (beta group), and no additional medication was administered to the other 148 patients (control group). When the heart rate was >60bpm on arrival, a β-blocker or verapamil was orally administered at the discretion of the physician. Although the baseline heart rate was not significantly different between the groups, the β-blocker treatment the night before significantly reduced the heart rate compared to control group upon arrival at the hospital and at the time of angiography. The rate of achievement of a heart rate ≤60bpm on arrival at the hospital was significantly higher in the beta group, and even after the additional treatment.
CONCLUSIONS: Bedtime administration of a long-acting β-blocker the night before coronary CT angiography is an effective option to achieve the target heart rate at the time of examination.
Copyright © 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Beta adrenergic receptors; Coronary disease; Heart rate; Tomography

Mesh:

Substances:

Year:  2014        PMID: 25113950     DOI: 10.1016/j.jjcc.2014.07.007

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  4 in total

1.  Salvianolic acid B induced upregulation of miR-30a protects cardiac myocytes from ischemia/reperfusion injury.

Authors:  Dan Li; Jun Wang; Jincai Hou; Jianhua Fu; Jianxun Liu; Ruichao Lin
Journal:  BMC Complement Altern Med       Date:  2016-09-01       Impact factor: 3.659

2.  Coronary Artery Disease Screening With Carotid Ultrasound Examination by a Primary Care Physician.

Authors:  Arihide Okahara; Kenji Sadamatsu; Taku Matsuura; Yasuaki Koga; Daigo Mine; Keiki Yoshida
Journal:  Cardiol Res       Date:  2016-02-20

3.  Shuangshen Ningxin Capsule, a Traditional Chinese Medicinal Preparation, Alleviates Myocardial Ischemia through Autophagy Regulation.

Authors:  Jun Wang; Jincai Hou; Chengren Lin; Jianhua Fu; Jianxun Ren; Lei Li; Hao Guo; Xiao Han; Bing Wang; Jianxun Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-11       Impact factor: 2.629

4.  The Functional Severity Assessment of Coronary Stenosis Using Coronary Computed Tomography Angiography-Based Myocardial Mass at Risk and Minimal Lumen Diameter.

Authors:  Kenji Sadamatsu; Kazuhiro Nagaoka; Yasuaki Koga; Kotaro Kagiyama; Kohei Muramatsu; Kiyoshi Hironaga; Hideki Tashiro; Takafumi Ueno; Yoshihiro Fukumoto
Journal:  Cardiovasc Ther       Date:  2020-01-30       Impact factor: 3.023

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.